- Home
- Clinical Trials
Hypertension Studies Waikato
Zenith Hypertension Study
Waikato
The ZENITH clinical research study for people with uncontrolled high blood pressure aims to find out if an investigational medication can help lower the risk of cardiovascular events, such as heart attack and stroke.
Are you living with high blood pressure?
You may be able to take part
Description
What to expect
Study details
Ages
18 or older
Duration
13-15 clinic visits over 2.5-5 years
Compensation
Participants will be reimbursed for their time and travel costs
Eligibility Criteria
You may be able to take part if:
- You’re 18 or older
- You are taking at least 2 medications for high blood pressure, including a diuretic (water pill)
- AND you have cardiovascular disease
OR
- You’re 55 or older
- You are taking at least 2 medications for high blood pressure, including a diuretic (water pill)
- AND you have a high risk of developing cardiovascular disease
Locations
Description
Are you at risk?
Several factors can increase your risk of cardiovascular disease, including smoking, obesity or having Type 1 or Type 2 diabetes.
What to expect
What does taking part involve?
The study doctor will go through your health details with you to see if the ZENITH study is a good fit. If you qualify and choose to take part, you'll be assigned at random (by chance) to receive either an investigational medication called zilebesiran (pronounced zile-BEE-siran) or a placebo. A placebo looks like and is given in the same way as zilebesiran, but does not contain any medication. There is a 50:50 chance that you will receive zilebesiran.
Screening period
You will need to visit the study site once or twice so the study doctors can assess whether the ZENITH study is a good fit for you.
Treatment period (up to 5 years)
You will need to attend 6 visits in the 1st year, and then 2 visits per year until the end of the study. Participation will depend on whether you experience any cardiovascular events, such as heart disease and stroke.
Participation in the ZENITH study is voluntary, and you can change your mind at any time. The study medication and health assessments are provided at no cost to you.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.